Invectys
Industry · 3 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Completed | EXPLORATORY STUDY Addendum to INVAC1-CT-101 (NCT02301754) Solid Tumor, Adult | Phase 1 | 2020-10-16 |
| Terminated | DNA Plasmid Encoding a Modified Human Telomerase Reverse Transcriptase (hTERT), Invac-1 in Chronic Lymphocytic Leukemia, Lymphocytic, Chronic, B-Cell | Phase 2 | 2018-07-25 |
| Completed | INVAC-1 Anti-Cancer hTERT DNA Immunotherapy Solid Tumors | Phase 1 | 2014-11-01 |